FDA Approved: RUFINAMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Rufinamide from Hikma Pharmaceuticals USA Inc., updating the labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lennox-gastaut Syndrome

Drugs mentioned

• Rufinamide (Rufinamide)

Snippet

SUPPL AP for RUFINAMIDE (RUFINAMIDE)